These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35041897)

  • 1. Protective immune potential of multiple antigenic peptide (MAP) constructs comprising peptides that are shared by several cysteine peptidases against Schistosoma mansoni infection in mice.
    Al-Naseri A; Al-Absi S; Mahana N; Tallima H; El Ridi R
    Mol Biochem Parasitol; 2022 Mar; 248():111459. PubMed ID: 35041897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hepatic interleukin-1, arachidonic acid, and reactive oxygen species mediate the protective potential of peptides shared by gut cysteine peptidases against Schistosoma mansoni infection in mice.
    Tallima H; El Ridi R
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011164. PubMed ID: 36920999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H; Tadros MM; El Ridi R
    Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against Schistosoma haematobium infection in hamsters by immunization with Schistosoma mansoni gut-derived cysteine peptidases, SmCB1 and SmCL3.
    Tallima H; Abou El Dahab M; Kareem S; Dalton JP; El Ridi R
    Vaccine; 2017 Dec; 35(50):6977-6983. PubMed ID: 29122387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.
    El Ridi R; Tallima H; Selim S; Donnelly S; Cotton S; Gonzales Santana B; Dalton JP
    PLoS One; 2014; 9(1):e85401. PubMed ID: 24465551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Protective Immune Responses Against Schistosomiasis haematobium in Hamsters and Mice Using Cysteine Peptidase-Based Vaccine.
    Tallima H; Dalton JP; El Ridi R
    Front Immunol; 2015; 6():130. PubMed ID: 25852696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papain-Based Vaccination Modulates Schistosoma mansoni Infection-Induced Cytokine Signals.
    Abdel Aziz N; Tallima H; Hafez EA; El Ridi R
    Scand J Immunol; 2016 Feb; 83(2):128-38. PubMed ID: 26603950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase.
    El Ridi R; Montash M; Tallima H
    Scand J Immunol; 2004 Oct; 60(4):392-402. PubMed ID: 15379864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.
    El Ridi R; Tallima H
    J Parasitol; 2013 Apr; 99(2):194-202. PubMed ID: 22985345
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H; Montash M; Veprek P; Velek J; Jezek J; El Ridi R
    Vaccine; 2003 Jul; 21(23):3290-300. PubMed ID: 12804860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Antibodies and Arachidonic Acid Mediate the Protection Induced by the
    Tallima H; Abou El Dahab M; El Ridi R
    Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33207535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of T lymphocytes and papain enzymatic activity in the protection induced by the cysteine protease against
    Tallima H; Abou El Dahab M; El Ridi R
    J Adv Res; 2019 May; 17():73-84. PubMed ID: 31193307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases.
    El Ridi R; Tallima H; Dalton JP; Donnelly S
    Front Genet; 2014; 5():119. PubMed ID: 24847355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
    Ahmad G; Zhang W; Torben W; Noor Z; Siddiqui AA
    Int J Infect Dis; 2010 Sep; 14(9):e781-7. PubMed ID: 20630783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating Immunization With Nucleotide Enzymes of
    Cagnazzo TDO; Nogueira CT; de Castro CA; Neris DM; Fattori ACM; Correia RO; Albuquerque YR; Fragelli BDL; Mendes TMF; Allegretti SM; Soares EG; Romanello L; Torini JR; Pereira HD; Anibal FF
    Front Immunol; 2020; 11():569988. PubMed ID: 33072110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
    PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.